MBRX Message Board Post 10862270 | Moleculin Biotech Inc.
home / stock / mbrx / mbrx message board
(investorshangout)
Posted on: Mar/30/2021 14:10:49
Source: investorshangout
https://investorshangout.com/post/view?id=6095469
whytestocks: $MBRX News Article - Moleculin Receives FDA Approval of Fast Track Designation for Annamycin in the
News, Short Squeeze, Breakout and More Instantly...
-
Moleculin to Participate in the Virtual Investor Lunch Break Series PR Newswire Live webcast with Walter Klemp , Chairman and Chief Executive Officer, on Wednesday, June 12 th at 12:00 PM ET HOUSTON , June 5, 2024 /PRNewswire/ -- Moleculin...
-
Moleculin Abstract Accepted for Poster Presentation at the European Hematology Association (EHA) 2024 Hybrid Congress PR Newswire HOUSTON , May 16, 2024 /PRNewswire/ -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage ...
-
Moleculin Announces Commencement of NIH-Funded Phase 2 Clinical Trial of STAT3 Inhibitor for the Treatment of Glioblastoma (NU 21C06) PR Newswire – Investigator-Initiated Phase 2 study is being conducted at Northwestern University in cooperation with Moleculin ...